ONCOTAG DIAGNOSTICS CO LTD has a total of 18 patent applications. Its first patent ever was published in 2018. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets measurement, biotechnology and foods and drinks are INOVA DIAGNOSTICS INC, BL CO LTD and ARQUER DIAGNOSTICS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | China | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | Australia | 1 | |
#6 | Brazil | 1 | |
#7 | Canada | 1 | |
#8 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Peptides | |
#3 | Enzymes | |
#4 | Microorganisms | |
#5 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Kwon Nam Hoon | 17 |
#2 | Kim Sunghoon | 13 |
#3 | Lee Dong Ki | 13 |
#4 | Lim Beom Jin | 12 |
#5 | Jang Sung Ill | 11 |
#6 | Kim Sung Hoon | 4 |
#7 | Yim Bum Jin | 1 |
#8 | Dong Ki Lee | 1 |
#9 | Nam Hoon Kwon | 1 |
#10 | Sung Ill Jang | 1 |
Publication | Filing date | Title |
---|---|---|
CA3074684A1 | Method for diagnosing pancreatic cancer using methionyl-trna synthetase, and pancreatic cancer diagnostic kit using same | |
KR20190026632A | Method for diagnosing pancreatic cancer using methionyl-tRNA synthetase and pancreatic acinar cell-specific marker | |
CN110998327A | Method for diagnosing cholangiocarcinoma by using methionyl-tRNA synthetase in cholangiocytes | |
WO2018208121A2 | Monoclonal antibody specifically binding to mrs |